PROM1 and cutaneous melanoma: Although the CD133 cell population co-expresses other stem cell markers or may represent overlapping markers, recent reports on metastatic melanoma containing CD133 and ABCG2-positive cells with enhanced tumorigenic potential further support our present findings on consistent expression of stemness marker CD133 in conjunction with ABCB5 in various progressive stages of cutaneous melanoma (25,26).